<DOC>
	<DOCNO>NCT00817622</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety EPA ( Eicosapentaenoic Acid ) alone VitE diabetic patient .</brief_summary>
	<brief_title>Effects EPA Vitamin E Leptin , Adiponectin Enzymatic Antioxidants Type 2 DM</brief_title>
	<detailed_description>Randomized , double-blind , placebo-controlled , parallel-group study design After 12weeks , subject type II DM randomize receive either 2000 mg pearl EPA per day plus double-blinded matching placebo ( 1 corn oil pearl per day ) 12 week OR 400 mg VitE pearl plus double-blinded per day plus double-blinded matching placebo ( 4 corn oil pearl per day ) 12 week OR 2000 mg pearl EPA per day plus double-blinded matching 400 mg VitE pearl OR placebo ( 4corn oil pearl per day plus 1 corn oil pearl per day ) 12 weeks.The total dose EPA pearl 2000 mg per day ( EPA match placebo corn oil dose remain 4 pearls per day ) The total dose VitE pearl 400 mg per day ( VitE match placebo corn oil dose remain 1 pearls per day ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>DM Type II . Antidiabetic drug therapy stop . History DM 215 year . Age 3055 year . No History circulatory , thyroid , pulmonary , liver , kidney , cancer . DM Type I. Nephropathy . Retinopathy . Cancer . Thyroid disease . Renal failure . pulmonary disease MI . CHD . Liver disease ,</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>diabetes mellitus type 2</keyword>
	<keyword>EPA</keyword>
	<keyword>leptin</keyword>
	<keyword>adiponectin</keyword>
</DOC>